A Controlled Clinical Trial Assessing the Efficacy of Vitamin B Prophylaxis in Attenuating Paclitaxel-induced Neuropathy and the Imperative Use of Gabapentin in Diabetic Ovarian Cancer Patients and the Potential Effect on Disease Response.

Clinical trial NCT07191587 · COMPLETED

Trial details

NCT number: NCT07191587
Sponsor: National Cancer Institute, Egypt
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Peripheral Neuropathy, Chemotherapy-induced Disease Management

Start date: 2024-12-01
Primary completion: 2025-04-30
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.